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Abstract: The antinociceptive activity of the Maytenus rigida Mart. (Celastraceae) 
ethanol extract and its ethyl acetate fraction as well as of (-)-4′-methylepigallocatechin 
(1), a previously isolated compound, was demonstrated in vivo. ED50 for 1 in the 
writhing test was 14.14 mg/kg. The acetic acid-induced writhing was inhibited by 98.4, 
84.4, and 58.3%, respectively, when mice were treated with the ethanol extract, ethyl 
acetate fraction, and 1. In the hot plate test, mice pretreated with 1 showed signifi cantly 
increased reaction times (60-89%). Oral administration of 1 signifi cantly inhibited fi rst 
and second phases of the formalin-induced pain (50 and 26.5%, respectively), whereas 
indomethacin inhibited only the second phase of the test (41.2%). Ethanol extract and its 
fraction showed effects on infl ammatory pain, while neurogenic and infl ammatory pain 
suppression by 1 is a strong indication of the presence of both central and peripheral 
effects and suggests its analgesic and anti-infl ammatory potential.
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Introduction
 The enormous fl oral diversity of Brazil has 
provided local traditional health practitioners with 
an impressive array of plant material from which to 
select ingredients for use in herbal medicines. Over the 
centuries, this “natural pharmacy” has been developed 
and refi ned to treat many human and animal disorders. 
Even with the enormous technological advances that 
have been made in conventional modern medicine, 
nearly 70% of population in Brazil still relies heavily on 
traditional healing practices and phytomedicines for their 
daily healthcare needs (Begossi et al., 2002; Lima et al., 
2006).
 In a continued study aimed to establish scientifi c 
basis for the popular and ethnomedical uses of common 
Brazilian medicinal plants, we have investigated the 
pharmacological activities and chemical constituents of 
Maytenus rigida Mart., Celastraceae. Maytenus genus is 
widespread in Northeast of Brazil and its root, bark, and 
leaves are used in folk medicine to treat infl ammation and 
pain (González et al., 2001; Mota & Albuquerque, 2002; 
Fenner et al., 2006; Reyes et al., 2006; Sosa et al., 2007). 
Several classes of secondary metabolites are represented 
within the genus, including triterpenes (Shirota et al., 1996, 
Estevam et al., 2009), oligo-nicotinated sesquiterpenes 
and sesquiterpene pyridine alkaloids (Corsino et al., 
1998), phenolic glycosides (Sannomiya et al., 1998), 
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agar furans (Gonzalez et al., 1993), and a number of 
phenolic compounds such as flavonoids, xanthones, 
catechins, leucoanthocyanidins and tannins (Estevam et 
al., 2009). Some of these compounds are used to treat 
painful conditions (Mota & Albuquerque, 2002), while 
others showed antiseptic, antiasthmatic, antitumoral, and 
fertility-regulating properties (Lee et al., 1982; Kuo et al., 
1990; Ghazanfar, 1994; Gonzalez et al., 1996). The book 
As Muitas Faces da Jurema (The Many Faces of Jurema) 
describes the use of the bark of M. rigida as a component 
of “jurema-preta” tea, known for its hallucinogenic 
properties (Mota & Albuquerque, 2002) and a previous 
study showed its antimicrobial activity (Estevam et 
al., 2009). Since M. rigida reportedly have analgesic 
activities (Mota & Albuquerque, 2002; Dias et al., 2007), 
the aim of the present study was better to investigate the 
antinociceptive (central and peripheral) properties of the 
ethanol extract of the plant, ethyl acetate fraction, and 
an isolated compound, using three in vivo mice models, 
namely, the acetic acid-induced writhing test, the hot 
plate test, and the formalin-induced nociception test.
Material and methods
Chemicals
 Analytical and spectroscopic grade solvents 
were obtained from Grupo Química (Rio de Janeiro, 
Brazil). Acetic acid, indomethacin, and formaldehyde 
were supplied by Merck (Darmstadt, Germany). Arabic 
gum and dypirone were purchased from Sigma (St. 
Louis, MO, USA), while morphine sulfate (Dimorf) was 
supplied by Cristália (Itapira, SP, Brazil). 
Plant material
 Maytenus rigida Mart., Celastraceae, stem barks 
were collected as previously described by Dias et al (2007) 
and a voucher specimen was deposited in the herbarium of 
the Federal University of Sergipe under reference number 
007677. Plant extract preparation, fractioning and (-)-4′-
methylepigallocatechin (1) isolation were previously 
described (Dias et al., 2007).
Animals
 Male Swiss mice obtained from breeding 
units at the Laboratory of Evaluation and Synthesis 
of Bioactive Substances, Federal University of Rio de 
Janeiro, Rio de Janeiro, Brazil, and from the Laboratory 
of Pharmacology and Immunity, Department of 
Physiology, Federal University of Alagoas, Maceió, 
Brazil, weighing between 20-30 g each, were used in 
the antinociceptive tests. The animals were kept at 25-
28 °C under a 12 h light/dark cycle with food and water 
provided ad libitum. The study was approved by the 
Research Ethics Committee of the Federal University 
of Alagoas (approval protocol UFAL N º 006443/2005-
78) and conducted according ethical guidelines for 
the care of laboratory animals and investigation of 
experimental pain in conscious animals (Zimmerman, 
1983).
Writhing antinociceptive test 
 
 The test was carried out using the method 
proposed by Koster et al. (1959) with modifications. 
Mice were randomly divided into groups of 10 to be 
orally pretreated with the crude ethanol plant extract 
(100 mg/kg), ethyl acetate fraction (100 mg/kg), and 
compound 1 (0.32-96.1 mg/kg), 60 min before the 
administration of 0.25 mL of 0.6% acetic acid by 
intraperitoneal injection. Positive control groups orally 
received the standard analgesic dypirone (0.1-100 mg/
kg) and the standard anti-inflammatory indomethacin 
(0.036-107.3 mg/kg), while negative control animals 
received a dose of the vehicle Arabic gum 5% (10 
mL/kg) before administering acetic acid. The number 
of abdominal writhes showed by each mouse was 
counted starting 10 min after injecting acetic acid, and 
counting was continued for 20 min. The antinociceptive 
activity was expressed as the percentage of inhibition 
of constrictions compared with the negative control 
group.
O
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OCH3
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Hot plate antinociceptive test
 The latency of the response in mice was 
measured using the hot plate test, which was carried out 
according to the method of Eddy & Leimback (1953) 
with minor modifications. Animals were previously 
chosen based on the response to heat. Only animals 
showing a reaction time within the range of 4-10 s were 
selected for inclusion in the test groups. Animals were 
placed on the heated surface of an Ugo Basile (Varese, 
Italy) DS 37 hot plate maintained at 55.5±1 °C, and 
latency was measured, which is defined as the time 
between placement and the first indication of licking 
of the paws or jumping. Groups of 10 mice were orally 
pretreated with the vehicle 5% Arabic gum (10 mL/kg, 
negative control, oral dose), compound 1 (32 mg/kg, 
Antinociceptive effects of an extract, fraction and an isolated compound of 
the stem bark of Maytenus rigida 
Marina V. Martins et al.
Rev. Bras. Farmacogn. Braz. J. Pharmacogn. 22(3): May/Jun. 2012600
oral dose) or morphine (4.25 mg/kg, positive control, 
i.p.). Treatment latencies were recorded at 0, 60, 90, 
120 and 150 min.
Formalin-induced pain test
 The formalin test was performed according 
to the method of Hunskaar & Hole (1987). Groups of 
ten mice were orally pretreated with either vehicle 5% 
arabic gum (10 mL/kg, negative control), compound 
1 (32 mg/kg) or indomethacin (12.9 mg/kg, positive 
control), and 60 min later with 2.5% formaldehyde (20 
μL) injected into the subplantar region of the right hind 
paw. The time each animal spent licking its paws during 
the first 5 min (first phase) and from 15 to 30 min (second 
phase) following injection was recorded. The test was 
performed at 22-26 °C and care was taken to exclude 
environmental disturbances (high temperature, noise 
and excessive movement) that might interfere with the 
natural response of the animal (Tjølsen et al., 1992).
  
Data analysis
 Results were recorded as mean values±SEM. 
The significance of differences between mean values was 
determined by ANOVA and Dunnett’s test for p≤0.05. 
The ED50 values were determined by linear regression 
using Graph Pad Prisma® software.
Results
Writhing test
 The antinociceptive activities of the crude 
ethanol extract of the stem bark of M. rigida, ethyl 
acetate fraction and 1 were initially evaluated using 
the acetic acid-induced writhing test. Administration 
of acetic acid by intraperitoneal injection to a negative 
control group of mice that had been orally pretreated with 
vehicle (arabic gum) induced 50.5±5 contortions during 
the observation period. On the other hand, in the groups 
of animals pretreated with ethanol extract and ethyl 
acetate fraction at 100 mg/kg, and 1 at 32 mg/kg, acetic 
acid-induced writhing was inhibited by 98.4, 84.4, and 
58.3%, respectively, all of which are values that differed 
significantly from that of the control (p<0.05, Figure 
1). The group of animals that received dypirone as a 
standard antinociceptive drug presented 56% of writhing 
inhibition compared with the control group.
 To further evaluate the effects of 1 on 
inflammatory pain, the relationship between the 
inhibition and doses of 1, dypirone (analgesic) and 
indomethacin (anti-inflammatory) were determined and 
are shown in Figure 2. The calculated ED50 for 1 was 
14.14 mg/kg, a value that is comparable with those of 
the reference drugs dypirone and indomethacin (Figure 
1). These data demonstrated that M. rigida possesses a 
potent anti-inflammatory effect, and suggest that 1 is one 
of the constituents responsible for this activity. Although 
no specific test for the toxicity or effect of 1 on motor 
activity was done, it was observed that treated animals did 
not show any apparent sign of toxicity such as lethargy, 
decreased motor activity, morbidity, or mortality, when 
monitored for 72 h after administration of the extract, 
fraction, and 1.
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Figure 1. Effect of the oral administration of vehicle 5% 
arabic gum (10 mL/kg), ethanol extract of Maytenus rigida 
(100 mg/kg), ethyl acetate fraction (100 mg/kg), (-)-4′-
methylepigallocatechin (1, 32 mg/kg), and dypirone (11 
mg/kg) on acetic acid-induced visceral pain in mice. Each 
point represents the mean number of abdominal constrictions 
measured over a 20 minute period (±SEM; n=10). Mean 
values indicated by bars bearing asterisks differ significantly 
(p< 0.05) from that of the negative control. 
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Figure 2. Dose-dependent effect of dypirone (0.100-100 mg/
kg), (-)-4′-methylepigallocatechin (1, 0.32-96.1 mg/kg), and 
indomethacin (0.036-107.3 mg/kg) on acetic acid-induced 
visceral pain in mice. Each point represents the mean percentage 
reduction in abdominal constrictions (±SEM; n=10). Mean 
values indicated by bars bearing asterisks differ significantly 
(p<0.05) from that of the negative control. In some cases error 
bars are obscured by the plot symbols.
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Hot plate test
 To confirm the antinociceptive effect of 1, and 
to find out whether the process is mediated by central 
or peripheral mechanisms, models to investigate the 
nociceptive activity were employed. In the hot plate test, 
mice pretreatment with 1 produced a significant increase 
(p<0.05) in the latency time between 60 and 150 min (60-
89%; Figure 3). Although the increase in latency induced 
by 1 following 30 min of post treatment was smaller than 
the one produced by morphine (70-161%), the effects 
generated by 1 and morphine were of similar duration 
and magnitude at 90, 120 and 150 min after pretreatment. 
These results suggest the antinociceptive of 1 is in part 
mediated by its central analgesic action. 
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Figure 3. Effect of the administration of vehicle 5% arabic 
gum (10 mL/kg, p.o.), (-)-4′-methylepigallocatechin (1, 32 
mg/kg, p.o.), and morphine (4.25 mgl/kg, i.p.) on latency in 
mice measured by the hot plate test. Each point represents the 
mean latency (±SEM; n=10). Mean values indicated by bars 
bearing asterisks differ significantly (p<0.001) from that of the 
negative control. In some cases, error bars are obscured by the 
plot symbols.
Formalin-induced pain test 
 The anti-inflammatory profile of 1 was 
determined using a classic nociception model based 
on the two phases of the formalin-induced pain test. 
As shown in Figure 4, oral administration of 1 induced 
significant reductions in the licking activity in both 
phases compared with the control (p<0.05) by 50 and 
26.5%, respectively, while indomethacin had no effect on 
the first phase, although it promote a 41.2% reduction in 
the licking activity in the second phase when compared 
with the control. These results suggest the antinociceptive 
activity of 1 is mediated by both central and peripheral 
mechanisms. 
 
Figure 4. Effect of oral administration of vehicle 5% arabic 
gum (10 mL/kg), indomethacin (12.9 mg/kg), and (-)-4′-
methylepigallocatechin (1, 32 mg/kg) on the first phase (0-5 
min, A) and second phase (15-30 min, B) of formalin-induced 
nociception in mice. Each point represents the mean time spent 
licking (±SEM; n=10). Mean values indicated by bars bearing 
asterisks differ significantly (p<0.001) from that of the negative 
control. In some cases, error bars are obscured by the plot 
symbols.
Discussion
 Although few studies have focused on the 
antinociceptive activity of plants in the Maytenus genus, 
a previous report showed antinociceptive effects of the 
hexane and ethyl acetate extracts of M. ilicifolia Mart. 
ex. Reiss at 320 mg/kg without any toxicity in mice 
(Jorge et al., 2004). Analgesic properties of Maytenus 
rigida Mart., Celastraceae, stem bark were previously 
investigated using the tail flick test, which showed the 
spinal antinociceptive potential of the plant extract and 
its ethyl acetate fractions at 100 mg/kg, which were 
chosen to be used in the present study, and 1. Although 
that study did not give extensive information on the 
action mechanism, it showed the involvement of the 
opioid receptor in the antinociception (Dias et al., 2007). 
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present study when 1 was administered to mice, strongly 
indicates the presence of both central and peripheral 
effects. 
Conclusions
 The present study supports the traditional 
use of M. rigida to treat painful and inflammatory 
conditions. To the best of our knowledge, it is the first 
report on the in vivo anti-inflammatory effects of the 
stem bark extract of M. rigida, as well as its ethyl 
acetate fraction. The (-)-4′-methylepigallocatechin 
(1) isolated of the plant showed antinociceptive 
activity by inducing both central and peripheral pain 
relief in mice. Thus, it confirms the pharmacological 
activities previously described for this species, which 
include analgesic (Mota & Albuquerque, 2002; Dias 
et al., 2007), insecticide, antiseptic, antiasthmatic and 
antitumor activities (Flores, 1998; Ghazanfar, 1994). 
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